My employer is promoting the Tour de Cure 150 mile bike ride which is done in April (from Knoxville, TN). I believe the entry requirement is to raise $150 from in donations and pay a $30 entry fee. Being a triathlete (thus already riding a few miles anyway) and having the type 1 disease myself, I am seriously considering signing on. However, I have a lot of unanswered questions about how this actually helps fund useful diabetes research, provides medications to those who cannot afford it, etc. I have seen these sorts of events take place for many years, but I'm left wondering where are the results? If research is being funded by all these charitable contributions, then shouldn't we be seeing some non-proprietary drugs and procedures entering the market? I looked on the Tour de Cure web site (http://tour.diabetes.org) and couldn't find any useful info as to what specific studies or activities are being funded. My own experiences with the U.S. health care system only compound my frustration with it. Upon diagnosis, the very first thing my doctor did was prescribe me two very expensive and very proprietary insulin formulations (Lantus and Novolog), for which I've ended up paying much of the costs out-of-pocket. On top of that, I've also been affected by the lack of availability of experimental treatments and all the hoops through which drug companies must jump before any significant portion of the population can benefit. In my case, I am speaking of the fact that I could not get access to a drug with high potential benefits and minimal side effects. Specifically, it was Diapep 277 - I tried to get into a clinical trial of this drug (with randomized 50% placebo) but failed because my c-peptide levels were too low. This drug has already been tested in other countries and found to stop or significantly slow the progression of type 1 diabetes. The catch is that it must be administered early enough to save the few remaining beta cells. It would not have gotten me off insulin, but it would have resulted in better control and lower insulin doses over the long run and probably only 1 daily basal injection instead of the 2 that I currently use. At this point, it is almost too late for this drug to be of benefit to me, except for the possibility of preserving the tiny remaining fraction of beta cells for future cloning. Logically, the mortality rate and severe complications associated with the type 1 disease should be weighed against the side effects of any new treatments. Unfortunately, this does not seem to be the case in the U.S., thus even well-funded research is doomed to years of waiting for regulatory approval while those with the disease are killed and maimed by it. Again, I'm left asking the question of who actually benefits from all these fund-raising events held by the ADA and others? If I cannot see good results from these sorts of events, then I cannot, in good conscience, ask my friends, family, fellow church members, etc. to support it.